HLA-C and neoplasm: Dendritic cells (DCs), the critical target of all cancer vaccines, are professional antigen presenting cells that play a pivotal role in orchestrating and coordinating anti-tumor immune responses, and are able to activate NK cells, B lymphocytes, and naïve and memory T cells by presenting tumor antigen/MHC complexes.